We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$157M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$112M
3
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$109M
4
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$73.1M
5
T icon
AT&T
T
+$64.5M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$134M
2
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$73.7M
3
DD icon
DuPont de Nemours
DD
+$64.2M
4
CCI icon
Crown Castle
CCI
+$45.2M
5
CSCO icon
Cisco
CSCO
+$42M

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVTA
2526
DELISTED
Avantax, Inc. Common Stock
AVTA
$589K ﹤0.01%
19,404
-1,347
-6% -$44.3K
DKL icon
2527
Delek Logistics
DKL
$3.17B
$587K ﹤0.01%
18,335
+3,885
+27% +$123K
ACIW icon
2528
ACI Worldwide
ACIW
$5.26B
$586K ﹤0.01%
17,056
-40,233
-70% -$1.33M
BRKL
2529
DELISTED
Brookline Bancorp
BRKL
$585K ﹤0.01%
38,058
-850
-2% -$12.7K
SNP
2530
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
$585K ﹤0.01%
8,578
+85
+1% +$6.18K
CVI icon
2531
CVR Energy
CVI
$3.39B
$583K ﹤0.01%
11,670
+2,520
+28% +$113K
HRTX icon
2532
Heron Therapeutics
HRTX
$61.1M
$582K ﹤0.01%
31,303
+6,448
+26% +$129K
SWX icon
2533
Southwest Gas
SWX
$6.66B
$581K ﹤0.01%
6,484
-523
-7% -$44.4K
CUT icon
2534
Invesco MSCI Global Timber ETF
CUT
$33.6M
$579K ﹤0.01%
21,451
-320
-1% -$8.54K
LEVI icon
2535
Levi Strauss
LEVI
$8.88B
$579K ﹤0.01%
27,724
+11,580
+72% +$255K
VC icon
2536
Visteon
VC
$2.85B
$577K ﹤0.01%
9,855
-2,112
-18% -$129K
CRBP icon
2537
Corbus Pharmaceuticals
CRBP
$185M
$574K ﹤0.01%
2,761
+542
+24% +$116K
PS
2538
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$574K ﹤0.01%
18,932
+2,417
+15% +$77.6K
GLAD icon
2539
Gladstone Capital
GLAD
$444M
$573K ﹤0.01%
30,563
+2,529
+9% +$47.1K
MCFT icon
2540
MasterCraft Boat Holdings
MCFT
$604M
$573K ﹤0.01%
29,259
+8,943
+44% +$204K
OUT icon
2541
Outfront Media
OUT
$5.31B
$572K ﹤0.01%
22,523
+11,391
+102% +$278K
CABO icon
2542
Cable One
CABO
$199M
$571K ﹤0.01%
488
– –
RMT
2543
Royce Micro-Cap Trust
RMT
$768M
$571K ﹤0.01%
69,454
-19,482
-22% -$161K
FCNCA icon
2544
First Citizens BancShares
FCNCA
$25.4B
$570K ﹤0.01%
1,265
-266
-17% -$116K
REET icon
2545
iShares Global REIT ETF
REET
$5.03B
$570K ﹤0.01%
21,370
+2,113
+11% +$56.4K
FUTY icon
2546
Fidelity MSCI Utilities Index ETF
FUTY
$2.29B
$568K ﹤0.01%
14,473
-198
-1% -$7.65K
FAB icon
2547
First Trust Multi Cap Value AlphaDEX Fund
FAB
$177M
$567K ﹤0.01%
10,524
+288
+3% +$15.5K
GTN icon
2548
Gray Television
GTN
$497M
$567K ﹤0.01%
34,576
-4,698
-12% -$93.1K
VNM icon
2549
VanEck Vietnam ETF
VNM
$508M
$565K ﹤0.01%
+35,241
New +$582K
MATX icon
2550
Matsons
MATX
$6.12B
$564K ﹤0.01%
14,517
-385
-3% -$14.6K
100 101
102
103 104

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.